JP5967900B2 - Taste improving agent - Google Patents
Taste improving agent Download PDFInfo
- Publication number
- JP5967900B2 JP5967900B2 JP2011238447A JP2011238447A JP5967900B2 JP 5967900 B2 JP5967900 B2 JP 5967900B2 JP 2011238447 A JP2011238447 A JP 2011238447A JP 2011238447 A JP2011238447 A JP 2011238447A JP 5967900 B2 JP5967900 B2 JP 5967900B2
- Authority
- JP
- Japan
- Prior art keywords
- mangosteen
- juice
- extract
- taste
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019640 taste Nutrition 0.000 title claims description 29
- 240000006053 Garcinia mangostana Species 0.000 claims description 59
- 235000017048 Garcinia mangostana Nutrition 0.000 claims description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 25
- 235000013305 food Nutrition 0.000 claims description 20
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 235000015203 fruit juice Nutrition 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 150000007964 xanthones Chemical class 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- QTDMGAWIBXJNRR-UHFFFAOYSA-N Mangostin Natural products CC(=CCc1c(O)cc2Oc3cc(C)c(O)c(CC=C(C)C)c3C(=O)c2c1O)C QTDMGAWIBXJNRR-UHFFFAOYSA-N 0.000 claims description 3
- GNRIZKKCNOBBMO-UHFFFAOYSA-N alpha-mangostin Chemical compound OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3OC2=C1 GNRIZKKCNOBBMO-UHFFFAOYSA-N 0.000 claims description 3
- ZVFQDLCERPGZMO-UHFFFAOYSA-N alpha-mangostin Natural products OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3CC2=C1 ZVFQDLCERPGZMO-UHFFFAOYSA-N 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 description 25
- 235000015192 vegetable juice Nutrition 0.000 description 13
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 12
- 240000003768 Solanum lycopersicum Species 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- 239000002798 polar solvent Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 235000013322 soy milk Nutrition 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000019629 palatability Nutrition 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000000825 pharmaceutical preparation Substances 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- YRKKJHJIWCRNCW-UHFFFAOYSA-N beta-Mangostin Chemical compound O1C2=CC(O)=C(OC)C(CC=C(C)C)=C2C(=O)C2=C1C=C(OC)C(CC=C(C)C)=C2O YRKKJHJIWCRNCW-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008123 high-intensity sweetener Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 235000015193 tomato juice Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- 208000017194 Affective disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000832224 Hypericaceae Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000021058 soft food Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Beans For Foods Or Fodder (AREA)
- Seasonings (AREA)
- Non-Alcoholic Beverages (AREA)
- Dairy Products (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Description
本発明は、マンゴスチンをエタノール溶媒抽出物からなる、飲食品の呈味改善剤に関する。
The present invention relates to a taste improver for foods and drinks comprising mangosteen as an ethanol solvent extract .
近年、食の欧米化により、野菜の摂取量が減少している。野菜ジュースは、各種のビタミン、ミネラル、植物性繊維、その他微量栄養素を豊富に含み、かつ、簡便に摂取できるため、野菜不足の解消、栄養補給、健康維持、美容などの目的としで飲用されている。しかしながら、多くの野菜ジュースには独特の青臭さ、野菜臭さを有するため、飲用に抵抗を持つ人も多い。豆乳飲料、トマト加工飲料でも同様の傾向が見られる。 In recent years, the intake of vegetables has decreased due to westernization of food. Vegetable juice is rich in various vitamins, minerals, vegetable fiber, and other micronutrients and can be consumed easily, so it is taken for the purpose of eliminating vegetable deficiency, nutritional supplementation, health maintenance, beauty, etc. Yes. However, since many vegetable juices have a unique blue odor and vegetable odor, many people have resistance to drinking. The same trend is seen in soy milk drinks and tomato processed drinks.
また、果汁入り飲料についても、各種ビタミンなどを豊富に含むことから、栄養補給、健康維持、美容等の目的として飲用されている。しかし、100%果汁入り飲料(特に柑橘類になど)には独特の苦味成分が多く含まれることから、果汁飲料における苦味のマスキングも課題とされている。また、果汁の種類によって、独特の風味を有し、忌避される場合もある。 Fruit juice-containing beverages are also drunk for the purpose of nutritional supplementation, health maintenance, beauty, and the like because they contain various vitamins. However, since beverages containing 100% fruit juice (particularly in citrus fruits and the like) contain many unique bitter components, masking of bitterness in fruit juice beverages is also an issue. Also, depending on the type of fruit juice, it has a unique flavor and may be avoided.
近年多く発売されるようになったアミノ酸入り飲料は、筋肉疲労軽減やスタミナ維持、代謝亢進などの健康維持を目的として飲用されている。しかし、イソロイシン、ロイシン、バリン、セリン、アスパラギン、グルタミン、アルギニン、リジン、システイン、メチオニン、フェニルアラニン、トリプトファン、ヒスチジン、プロリンなどの多くのL型アミノ酸が、濃度によっては苦味を有することが分かっている。実際、アミノ酸飲料は、苦味を呈することが多く、アミノ酸による苦味をマスキングすることが課題とされている。 In recent years, beverages containing amino acids, which have been put on the market in large numbers, have been drunk for the purpose of maintaining health such as reducing muscle fatigue, maintaining stamina, and increasing metabolism. However, many L-type amino acids such as isoleucine, leucine, valine, serine, asparagine, glutamine, arginine, lysine, cysteine, methionine, phenylalanine, tryptophan, histidine, proline and the like have been found to have a bitter taste depending on the concentration. In fact, amino acid beverages often have a bitter taste, and masking the bitter taste caused by amino acids has been a problem.
飲料の異味の低減には、ペプチドを添加する方法(例えば、特許文献1参照)やトレハロースを添加する方法(例えば、特許文献2参照)などがある。また、高甘味度甘味料であるネオテームを添加する方法(例えば、特許文献3参照)が報告されているが、高甘味度甘味料はそれ自身に苦味や金属味などの異味があり、異味をマスキングするために使用量を増やすと渋みをマスキングする一方で、嗜好性に影響を及ぼすことがあるといった課題もある。しかし、いずれにしても、最近では消費者の添加物に対する意識が強くなっており、安全性をイメージしやすい、天然素材が求められている。また、味、臭いに特異な厭味が少ないことを求める傾向とともに、糖類や塩類についてはその使用量を抑制する傾向にある。 To reduce the taste of beverages, there are a method of adding a peptide (for example, see Patent Document 1) and a method of adding trehalose (for example, see Patent Document 2). In addition, a method of adding neotame, which is a high-intensity sweetener (see, for example, Patent Document 3) has been reported. However, a high-intensity sweetener has its own tastes such as bitterness and metallic taste. While increasing the amount used for masking masks astringency, there is also a problem that it may affect palatability. In any case, however, consumers have recently become more aware of additives, and there is a need for natural materials that are easy to imagine safety. In addition, there is a tendency to reduce the amount of sugars and salts used, as well as a tendency to demand less taste specific to taste and smell.
マンゴスチン(Mangosteen 学名:Garcinia mangostana L.)は、東南アジアを原産とするオトギリソウ科の植物である。マンゴスチンの果実又は果皮は、伝統的に、赤痢や伝染性下痢症の治療薬、抗菌や寄生虫駆除、マラリア、尿路感染症、梅毒、淋病の治療薬などとして使用されている(例えば、非特許文献1参照)。また、5α−レダクターゼ阻害剤(例えば、特許文献4参照)、美白・抗炎症作用(例えば、特許文献5参照)、IκBキナーゼ阻害剤(例えば、特許文献6参照)としての利用法も知られている。しかしながら、本発明のように、呈味改善作用を有することについては何ら知られていない。
また、マンゴスチンジュースの製造工程において果皮等を含む搾汁残渣が多量に副生されるが、上記の効果を訴求した商品への利用は少なく、通常はほとんどが廃棄されている。搾汁残渣は、腐敗しやすく、公害防止の観点からも処理策が求められている。
Mangosteen (Mangosteen scientific name: Garcinia mangostana L.) is a hypericaceae plant native to Southeast Asia. Mangosteen fruit or peel is traditionally used as a treatment for dysentery and infectious diarrhea, antibacterial and parasite control, malaria, urinary tract infections, syphilis, gonorrhea, etc. Patent Document 1). Moreover, the utilization method as a 5 (alpha) -reductase inhibitor (for example, refer patent document 4), whitening and anti-inflammatory action (for example, refer patent document 5), and I (kappa) B kinase inhibitor (for example, refer patent document 6) is also known. Yes. However, nothing is known about having a taste improving effect as in the present invention.
In addition, a large amount of squeezed residue including pericarp etc. is produced as a by-product in the manufacturing process of mangosteen juice, but it is rarely used for products that appeal to the above effects, and most of them are usually discarded. The squeezed residue is easily rotted, and treatment measures are required from the viewpoint of pollution prevention.
本発明は、飲食品が本来有する味を損なうことなく、安全かつ安価に、飲食品の青臭さ(野菜臭さ、豆臭さなど)、苦味、エグ味などの異味を低減すると共に、コクの付与、甘みの付与などの有益な作用を兼ね備えた呈味改善剤を提供することを目的とする。 The present invention reduces the off-flavors of food and drink, such as the blue odor (vegetable smell, bean odor, etc.), bitterness, and taste, without sacrificing the original taste of the food or drink. It aims at providing the taste improving agent which has useful effects, such as provision of provision and sweetness.
本発明者は、上記課題を解決するために、鋭意検討を重ねた結果、マンゴスチン抽出物が飲食品、特に野菜ジュース飲料、トマト加工飲料、豆乳などの飲料の風味を改善し、嗜好性が向上させることを発見した。
As a result of intensive studies in order to solve the above problems, the present inventor has improved mangosteen extract flavor of beverages such as foods and beverages, especially vegetable juice beverages, tomato processed beverages, soy milk, and palatability. I found out that
本発明者による前記の知見に基づく本発明は、以下の通りである:
(1)マンゴスチン果実、果汁、濃縮果汁、搾汁残渣、果皮及び/又はこれらの乾燥物から選ばれる1種又は2種以上の原料のエタノール溶媒抽出物からなる、飲食品の呈味改善剤。
(2)キサントン類を0.01%以上含有する、上記(1)に記載の呈味改善剤。
(3)α−マンゴスチンを0.01%以上含有する、上記(1)に記載の呈味改善剤。
(4)飲食品に上記(1)〜(3)のいずれか1項に記載の呈味改善剤を添加する工程を含む呈味改善方法。
Based on the above findings by the present inventors, the present invention is as follows:
(1) A taste improver for foods and drinks comprising an ethanol solvent extract of one or more raw materials selected from mangosteen fruit, fruit juice, concentrated fruit juice, juice residue, fruit skin and / or dried products thereof.
(2) The taste improver according to (1) above, containing xanthones in an amount of 0.01% or more.
(3) The taste improving agent according to (1) above, containing α-mangosteen in an amount of 0.01% or more.
(4) Taste improvement method including the process of adding the taste improving agent of any one of said (1)-( 3 ) to food-drinks.
本発明によれば、飲食品、特に野菜ジュース飲料、トマト加工飲料、豆乳の風味を改善し、嗜好性を向上させた飲料を製造することができる。 ADVANTAGE OF THE INVENTION According to this invention, the drink which improved the flavor of food-drinks, especially vegetable juice drink, a tomato processed drink, and soymilk, and improved palatability can be manufactured.
以下、本発明を実施するための形態について詳細に説明する。なお、本発明は以下の実施の形態に限定されるものではなく、その要旨の範囲内で種々変形して実施することができる。 Hereinafter, embodiments for carrying out the present invention will be described in detail. In addition, this invention is not limited to the following embodiment, It can implement by changing variously within the range of the summary.
本発明の呈味改善剤は、マンゴスチン果実、果汁、濃縮果汁、搾汁残渣、果皮及び/又はこれらの乾燥物から選ばれる1種又は2種以上の原料(以下、単に「マンゴスチン原料」と略記する場合がある)を極性溶媒で抽出した処理物である(以下、極性溶媒を用いた抽出処理をして得られる処理物を単に「マンゴスチン抽出物」と略記する場合がある)。 The taste improving agent of the present invention is one or more raw materials selected from mangosteen fruit, fruit juice, concentrated fruit juice, juice residue, pericarp and / or dried products thereof (hereinafter simply referred to as “mangosteen raw material”). Is a processed product extracted with a polar solvent (hereinafter, a processed product obtained by extraction using a polar solvent may be simply abbreviated as “mangostin extract”).
マンゴスチン原料は、特に限定されず、マンゴスチン果実や果皮等の固形分を含んでいてもよく、マンゴスチン果実や果皮等の固形分をろ過により除去した溶液であってもよい。 The mangosteen raw material is not particularly limited, and may contain solids such as mangosteen fruit and fruit skin, or may be a solution obtained by removing solids such as mangosteen fruit and fruit skin by filtration.
マンゴスチンジュースなどに用いるマンゴスチンの搾汁液は、マンゴスチン果実を洗浄し、果皮を除き、破砕したのち、これを搾汁して得られる。この搾汁の過程において、搾汁残渣や果皮が発生する。搾汁残渣や果皮にはキサントン類が豊富に含まれている。
上記搾汁残渣や果皮は、一般的に廃棄されるか、家畜飼料となるが、この搾汁残渣や果皮を用いれば、廃棄原料を有効利用でき、しかも高濃度のキサントン類を含む組成物を容易に効率よく得ることができるため好ましい。
Mangosteen juice used for mangosteen juice, etc. is obtained by washing mangosteen fruit, removing the peel and crushing it, and then squeezing it. In the process of squeezing, squeezed residue and fruit skin are generated. The juice residue and pericarp are rich in xanthones.
The squeezed residue and peel are generally discarded or used as livestock feed, but if this squeezed residue and peel are used, the waste raw material can be used effectively, and a composition containing a high concentration of xanthones is used. It is preferable because it can be obtained easily and efficiently.
マンゴスチン原料の極性溶媒を用いた抽出の温度は、0℃〜極性溶媒の沸点程度であり、通常は常温で行う。極性溶媒としてエタノールを使用する場合、抽出効率の観点から、0℃以上55℃未満が好ましく、5℃以上40℃以下がより好ましい。作業容易性の観点から、室温程度の25℃前後で抽出を行うことが特に好ましい。
抽出時間は、1分〜24時間が好ましいが、これより長時間抽出を行っても良い。抽出は、静置、攪拌のいずれでもよい。マンゴスチン原料に1〜50倍量、好ましくは5〜20倍量程度の極性溶媒を加え抽出することによって、マンゴスチン抽出物を得ることができる。抽出効率を高めるため、マンゴスチン原料は乾燥品であってもよい。
The extraction temperature of the mangosteen raw material using a polar solvent is about 0 ° C. to the boiling point of the polar solvent, and is usually performed at room temperature. When ethanol is used as the polar solvent, it is preferably 0 ° C. or higher and lower than 55 ° C., more preferably 5 ° C. or higher and 40 ° C. or lower from the viewpoint of extraction efficiency. From the viewpoint of workability, it is particularly preferable to perform extraction at around 25 ° C., which is about room temperature.
The extraction time is preferably 1 minute to 24 hours, but the extraction may be performed for a longer time. Extraction may be either stationary or stirring. A mangosteen extract can be obtained by adding 1 to 50 times, preferably 5 to 20 times, a polar solvent to the mangosteen raw material for extraction. In order to increase extraction efficiency, the mangosteen raw material may be a dried product.
極性溶媒としては、食品添加物の抽出溶剤となり得る極性溶媒であれば特に限定されず、例えば、アセトン、エタノール、エチルメチルケトン、グリセリン、酢酸エチル、酢酸メチル、ジエチルエーテル、シクロヘキサン、ジクロロメタン、食用油脂、1,1,1,2−テトラフルオロエタン、1,1,2−トリクロロエテン、1−ブタノール、2−ブタノール、1−プロパノール、2−プロパノール、プロピレングリコール、ヘキサン、水、メタノール等から選択される1又は複数の有機溶媒を用いることができる。
これらのうち好ましくは、エタノール(10体積%以上90体積%未満)、メタノール(10体積%以上90体積%未満)、1−ブタノール(30体積%以上90体積%未満)及びヘキサン(5体積%70体積%未満)から選択される有機溶媒を用いることができ、最も好ましくはエタノールを用いることができる。
例えば、極性溶媒として、10体積%以上90体積%未満のエタノール溶媒を用いることができ、好ましくは30体積%以上70体積%以下のエタノール溶媒を用いることができ、より好ましくは70体積%程度のエタノール溶媒用いることができる。なお、70体積%のエタノール溶媒とは、水とエタノールの体積比3:7の混合物を指す。
The polar solvent is not particularly limited as long as it is a polar solvent that can be an extraction solvent for food additives. For example, acetone, ethanol, ethyl methyl ketone, glycerin, ethyl acetate, methyl acetate, diethyl ether, cyclohexane, dichloromethane, edible fats and oils 1,1,1,2-tetrafluoroethane, 1,1,2-trichloroethene, 1-butanol, 2-butanol, 1-propanol, 2-propanol, propylene glycol, hexane, water, methanol, etc. One or more organic solvents can be used.
Of these, ethanol (10 to 90% by volume), methanol (10 to 90% by volume), 1-butanol (30 to 90% by volume) and hexane (5% by volume 70) are preferable. An organic solvent selected from less than volume%) can be used, and most preferably ethanol can be used.
For example, an ethanol solvent of 10% by volume or more and less than 90% by volume can be used as the polar solvent, preferably an ethanol solvent of 30% by volume or more and 70% by volume or less can be used, more preferably about 70% by volume. An ethanol solvent can be used. The 70% by volume ethanol solvent refers to a mixture of water and ethanol in a volume ratio of 3: 7.
本発明におけるマンゴスチン抽出物は、溶液状やピューレ状であってもよく、適当な濃度まで減圧濃縮又は膜濃縮することによって濃厚な液状組成物とすることも可能である。マンゴスチン抽出物を乾燥させて得られる固形物であってもよい。 The mangosteen extract in the present invention may be in the form of a solution or puree, and can also be made into a concentrated liquid composition by concentration under reduced pressure or membrane concentration to an appropriate concentration. It may be a solid obtained by drying the mangosteen extract.
極性溶媒を用いた抽出処理をして得られるマンゴスチン抽出物は、溶液状物をドラム式乾燥、噴霧乾燥又は凍結乾燥したものであってもよく、乾燥物とすることにより保存安定性に優れる。 The mangosteen extract obtained by the extraction treatment using a polar solvent may be a solution-like product obtained by drum-type drying, spray-drying or freeze-drying, and is excellent in storage stability by using a dried product.
マンゴスチン抽出物の添加量は、呈味改善剤としての精製度によっても多少異なるが、本発明のマンゴスチン抽出物が、味・臭いに特異な厭味が少ないことから、比較的広範な濃度で添加することができる。本発明のマンゴスチン抽出物を果汁、野菜ジュース、トマト加工飲料、ミックスジュース、豆乳等の飲食品に配合した場合、マンゴスチン抽出物を添加しても、果汁、野菜ジュース、トマト加工飲料、ミックスジュース、豆乳の本来の味が損なわれず、マンゴスチン抽出物を添加しない飲食品と比較して風味が損なわれない。
マンゴスチン抽出物を飲料に添加する場合には、1,000mL当り、乾燥物換算で、好ましくは10mg〜25,000mg、より好ましくは100mg〜10,000mgである。
Although the amount of mangosteen extract added varies slightly depending on the degree of purification as a taste improver, the mangosteen extract of the present invention has a relatively wide range of concentrations because it has less taste and odor specific taste. be able to. When the mangosteen extract of the present invention is blended with food and drink such as fruit juice, vegetable juice, tomato processed drink, mixed juice, soy milk, even if the mangosteen extract is added, fruit juice, vegetable juice, tomato processed drink, mixed juice, The original taste of soy milk is not impaired, and the flavor is not impaired as compared with foods and drinks to which no mangosteen extract is added.
When a mangosteen extract is added to a beverage, it is preferably 10 mg to 25,000 mg, more preferably 100 mg to 10,000 mg per 1,000 mL in terms of dry matter.
マンゴスチン抽出物には、キサントン類を0.01%以上含有することが望ましい。αーマンゴスチン、βーマンゴスチン、γーマンゴスチン、ガルタニン及び8−デオキシガルタニンの総量をキサントン類の総量として規定することができる。
キサントン類は、マンゴスチン抽出物をDMSOに溶解し、試料溶液をフィルター(0.45μm)で濾過し、逆相系カラムを装着した高速液体クロマトグラフを用いて分析することができる。移動相A液は、0.1%ギ酸を含有した蒸留水、移動相B液は0.1%ギ酸を含有したアセトニトリル溶液とし、試料注入量は10μLとして、検出はフォトダイオードアレイ検出器により行うことができる。
The mangosteen extract preferably contains 0.01% or more of xanthones. The total amount of α-mangostin, β-mangostin, γ-mangosteen, gartanine and 8-deoxygartanine can be defined as the total amount of xanthones.
Xanthones can be analyzed using a high-performance liquid chromatograph equipped with a reversed-phase column after dissolving the mangosteen extract in DMSO, filtering the sample solution with a filter (0.45 μm). The mobile phase A solution is distilled water containing 0.1% formic acid, the mobile phase B solution is acetonitrile solution containing 0.1% formic acid, the sample injection volume is 10 μL, and detection is performed by a photodiode array detector. be able to.
マンゴスチン抽出物中のα−マンゴスチン量は、0.001%以上含有することが望ましく、より好ましくは0.01%以上である。飲食品としては、0.0001%以上含有することが望ましい。しかしながら、長期間に亘って健康維持の目的で摂取する場合には、上記範囲より少量であってもよい。 The amount of α-mangosteen in the mangosteen extract is desirably 0.001% or more, and more preferably 0.01% or more. As food and drink, it is desirable to contain 0.0001% or more. However, when ingested for the purpose of maintaining health over a long period of time, the amount may be smaller than the above range.
本発明のマンゴスチン抽出物は、呈味改善剤としてばかりでなく、そのまま飲食品として、特定保健用食品、栄養機能食品、健康食品、機能性食品、健康補助食品等として利用できる他、更に食品添加物、例えば、甘味料、着色料、保存料、増粘安定剤、酸化防止剤、苦味料、酸味料、乳化剤、強化剤、製造用剤及び香料などを添加して各種製剤として用いることもでき、清涼飲料水や食品に配合する香味料組成物としても利用することができる。 The mangosteen extract of the present invention can be used not only as a taste improver but also as a food and drink as it is, as a food for specified health use, nutritional functional food, health food, functional food, health supplement, etc. Products such as sweeteners, coloring agents, preservatives, thickening stabilizers, antioxidants, bittering agents, sour agents, emulsifiers, reinforcing agents, manufacturing agents, and flavoring agents can be added and used as various preparations. It can also be used as a flavoring composition to be blended in soft drinks and foods.
飲食品として好ましい形態は、飴、ゼリー、錠菓、飲料、スープ、麺、煎餅、和菓子、冷菓、焼き菓子等の食品や飲料であり、好ましくは、果汁飲料、野菜ジュース、果物野菜ジュース、茶飲料、コーヒー飲料、スポーツドリンク等の容器詰飲料である。 Preferred forms as food and drink are foods and beverages such as candy, jelly, tablet confectionery, beverages, soup, noodles, rice crackers, Japanese confectionery, frozen confectionery, baked confectionery, etc., preferably fruit juice beverages, vegetable juices, fruit vegetable juices, teas It is a packaged beverage such as a beverage, a coffee beverage or a sports drink.
マンゴスチン抽出物の飲食品、ダイエット用の組成物としての摂取量は、用途に応じて適宜調整することができるが、乾燥物換算で、好ましくは1回10mg〜25,000mgであり、より好ましくは1回100mg〜10,000mg、さらに好ましくは1回100mg〜1,000mgである。摂取回数は、特に限定されないが、好ましくは1日1〜3回であり、必要に応じて摂取回数を増減してもよい。 The intake of the mangosteen extract as a food / beverage product or diet composition can be appropriately adjusted according to the intended use, but is preferably 10 mg to 25,000 mg at a time in terms of dry matter, more preferably It is 100 mg to 10,000 mg at a time, more preferably 100 mg to 1,000 mg at a time. The number of intakes is not particularly limited, but is preferably 1 to 3 times a day, and the number of intakes may be increased or decreased as necessary.
本発明のマンゴスチン抽出物は、医薬品として、薬学的に許容可能な賦形剤を添加して、医薬製剤として用いることができる。医薬製剤としては、粉末、顆粒、錠剤等の公知の剤型に製剤化して用いることができ、液体、ペースト等の液剤として用いることもできる。 The mangosteen extract of the present invention can be used as a pharmaceutical preparation by adding a pharmaceutically acceptable excipient as a pharmaceutical. As a pharmaceutical preparation, it can be formulated into a known dosage form such as powder, granule or tablet, and can also be used as a liquid preparation such as liquid or paste.
医薬製剤としては、錠剤、カプセル剤、顆粒剤、細粒剤、散剤、液剤、シロップ剤、チュアブル、トローチ等の経口剤、注射剤、舌下剤、吸入剤、点眼剤、坐剤等の剤形として用いることができる。医薬製剤の剤形として、好ましくは、錠剤、カプセル剤、散剤、顆粒剤、注射剤である。 Pharmaceutical preparations include tablets, capsules, granules, fine granules, powders, liquids, syrups, chews, lozenges, injections, sublinguals, inhalants, eye drops, suppositories, etc. Can be used as The dosage form of the pharmaceutical preparation is preferably a tablet, capsule, powder, granule, or injection.
マンゴスチン抽出物の医薬品としての投与量は、個々の薬剤の活性、患者の症状、年齢、体重等の種々の条件により適宜調整することができるが、例えば、乾燥物換算で、好ましくは1回10mg〜25,000mgであり、より好ましくは1回100mg〜10,000mg、さらに好ましくは1回100mg〜1,000mgである。マンゴスチン抽出物に含まれるα−マンゴスチンとしては1回0.1mg〜25mgであり、好ましくは1mg〜10mgである。投与回数は、特に限定されないが、好ましくは1日1〜3回であり、必要に応じて投与回数を増減してもよい。
上記医薬製剤は、抗ストレス(ストレス解消)用、リラックス用、抗不安用、精神安定用、鎮静用、興奮抑制用、行動障害改善用、衝動性抑制用、情動障害改善用、又は多動性抑制用の用途として期待できる。また、動物、中でも哺乳類(イヌ、ネコ、ウシ、ウマなどが挙げられる)においても同様である。
The dose of the mangosteen extract as a pharmaceutical can be adjusted as appropriate according to various conditions such as the activity of each drug, the patient's symptoms, age, weight, etc. For example, preferably 10 mg once in terms of dry matter. ˜25,000 mg, more preferably 100 mg to 10,000 mg at a time, and even more preferably 100 mg to 1,000 mg at a time. The α-mangosteen contained in the mangosteen extract is 0.1 mg to 25 mg at a time, preferably 1 mg to 10 mg. The number of administrations is not particularly limited, but is preferably 1 to 3 times a day, and the number of administrations may be increased or decreased as necessary.
The above pharmaceutical preparations are for anti-stress (stress relief), relaxation, anti-anxiety, tranquilization, sedation, arousal suppression, behavioral disorder improvement, impulsiveness suppression, affective disorder improvement, or hyperactivity It can be expected as a use for suppression. The same applies to animals, especially mammals (including dogs, cats, cows, horses, etc.).
以下、本発明を実施例及び比較例により具体的に説明するが、本発明は、これらの実施例に何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example and a comparative example demonstrate this invention concretely, this invention is not limited to these Examples at all.
[実施例1]
(1)マンゴスチン抽出物の製造
タイから100%果肉部を含むマンゴスチンジュース(以下、100%果肉部マンゴスチンジュース)、70%果肉部30%果皮抽出物を含むマンゴスチンジュース(以下、70%果肉部マンゴスチンジュース)を輸入した。果皮抽出物は、マンゴスチン果実を洗浄し、マンゴスチン果実ジュースを得る過程で発生した果皮を熱水で抽出した後、濾過して得られた果皮の熱水抽出液である。
それぞれ1Lのジュースに、4倍量の99.5%エタノールを加え、室温で2時間攪拌後、濾紙を用いて濾過し、液層をエバポレーターにより濃縮し、凍結乾燥することで、100%果肉部マンゴスチンジュースでは196g、70%果肉部マンゴスチンジュースでは142.7gの抽出物を得た。
得られた各抽出物をDMSOに溶解し、試料溶液をフィルター(0.45μm)で濾過し、逆相系カラム(Capcell Pak C18、4.6mm×250mm、資生堂社製)を装着した高速液体クロマトグラフ(型式600、Waters社製)を用いて分析した。移動相A液は0.1%ギ酸を含有した蒸留水、B液は0.1%ギ酸を含有したアセトニトリル溶液とし、試料注入量は10μL、検出はフォトダイオードアレイ検出器(型式2996、Waters社製)により行った。抽出物に含まれるキサントン類量の結果を表1に示す。
[Example 1]
(1) Mangosteen extract production Mangosteen juice containing 100% pulp part from Thailand (hereinafter, 100% pulp part mangosteen juice), Mangosteen juice containing 70% pulp part 30% skin extract (hereinafter, 70% pulp part mangosteen) Juice). The pericarp extract is a hot water extract of pericarp obtained by washing mangosteen fruit and extracting the pericarp generated in the process of obtaining mangosteen fruit juice with hot water, followed by filtration.
Add 49.5 volumes of 99.5% ethanol to each 1L of juice, stir at room temperature for 2 hours, filter using filter paper, concentrate the liquid layer with an evaporator, and freeze-dry. Mangosteen juice yielded an extract of 196 g, and 70% pulp mangosteen juice yielded an extract of 142.7 g.
Each obtained extract was dissolved in DMSO, the sample solution was filtered with a filter (0.45 μm), and a high performance liquid chromatograph equipped with a reverse phase system column (Capcell Pak C18, 4.6 mm × 250 mm, manufactured by Shiseido Co., Ltd.). Analysis was performed using a graph (model 600, manufactured by Waters). The mobile phase A solution is distilled water containing 0.1% formic acid, the B solution is acetonitrile solution containing 0.1% formic acid, the sample injection volume is 10 μL, and the detection is a photodiode array detector (model 2996, Waters). Made). Table 1 shows the result of the amount of xanthones contained in the extract.
[実施例2]
(2)マンゴスチン抽出物の含有飲料及び食品の官能評価
市販の野菜ジュース(食塩無添加)、トマト加工飲料(食塩無添加)、豆乳(無調製)に100%果肉部マンゴスチンジュース抽出物及び70%果肉部マンゴスチンジュース抽出物を1重量%含有する飲料をそれぞれ作製し、嗜好性、青臭さ(トマト臭さ、豆臭さを含む)に関してパネラー10又は11名による官能評価を行った。
抽出物を添加しない飲料(対照)の嗜好性及び青臭さの強さを5段階中3としたときの、各飲料の嗜好性及び青臭さの強さを5段階で評価し、パネラー10又は11名の評価の平均を算出した。結果を表2〜4に示す。*はコントロール群に対する各群のTukey法による有意差を示す。
70%果肉部マンゴスチンジュース抽出物及び100%果肉部マンゴスチンジュース抽出物を添加することで、野菜ジュース、トマト加工飲料、豆乳の甘みが増加した。70%果肉部マンゴスチンジュース抽出物を添加することで、野菜ジュースの青臭さが低減され、嗜好性が向上した飲料となった。トマトジュースでは、70%果肉部マンゴスチンジュース抽出物及び100%果肉部マンゴスチンジュース抽出物を添加することで、トマトジュースの青臭さ(トマト臭さ)が低減され、嗜好性が向上した。豆乳では、70%果肉部マンゴスチンジュース抽出物を添加することで、青臭さ(豆臭さ)が低減し、嗜好性が向上した。結果を表2〜4に示す。
[Example 2]
(2) Sensory Evaluation of Mangosteen Extract Containing Beverages and Foods 100% Flesh Mangosteen Juice Extract and 70% to commercially available vegetable juice (no salt added), tomato processed beverage (no salt added), soy milk (no preparation) Beverages containing 1% by weight of the pulp part mangosteen juice extract were prepared, and sensory evaluation was performed by panelists 10 or 11 on palatability and blue odor (including tomato odor and bean odor).
When the taste of the beverage (control) to which the extract is not added (control) and the intensity of the blue odor are set to 3 out of 5 levels, the taste and the intensity of the blue odor of each beverage are evaluated in 5 levels. The average of the name evaluation was calculated. The results are shown in Tables 2-4. * Indicates a significant difference of each group by the Tukey method relative to the control group.
By adding 70% pulp part mangosteen juice extract and 100% pulp part mangosteen juice extract, the sweetness of vegetable juice, tomato processed drink, and soy milk increased. By adding 70% pulp part mangosteen juice extract, the blue odor of vegetable juice was reduced, and a beverage with improved palatability was obtained. In tomato juice, the blue odor (tomato odor) of tomato juice was reduced and the palatability was improved by adding 70% pulp part mangosteen juice extract and 100% pulp part mangosteen juice extract. In soymilk, by adding 70% pulp part mangosteen juice extract, blue odor (bean odor) was reduced and palatability was improved. The results are shown in Tables 2-4.
本発明のマンゴスチン抽出物を有効成分とする組成物は、飲食品(特に野菜ジュース、トマト加工飲料、豆乳)に添加することにより、甘みの増加、青臭さ(トマト臭さ、豆臭さ)の低減により風味が改善し、嗜好性を向上させることができる。また、天然物素材であるため、安全性も高く、長期摂取も可能である。本発明は、また、医薬品、飲食品等の分野で有用である。キサントン類を含むマンゴスチン抽出物を飲食品(特に野菜ジュース、トマト加工飲料、豆乳)に添加することにより、風味が損なわれず、負担なくキサントン類を継続摂取することが可能となる。さらに、本発明によれば、該組成物をマンゴスチン搾汁残渣より容易に効率よく分離することができるため、廃棄物の有効利用が可能である。 A composition comprising the mangosteen extract of the present invention as an active ingredient is added to foods and drinks (especially vegetable juice, processed tomato beverage, soy milk) to increase sweetness, blue odor (tomato odor, bean odor). By reducing the flavor, the taste can be improved. Moreover, since it is a natural product material, it is highly safe and can be taken for a long time. The present invention is also useful in the fields of pharmaceuticals, food and drinks, and the like. By adding the mangosteen extract containing xanthones to foods and drinks (particularly vegetable juice, processed tomato beverage, soy milk), the flavor is not impaired and the xanthones can be ingested without burden. Furthermore, according to the present invention, since the composition can be easily and efficiently separated from the mangosteen juice residue, waste can be effectively used.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011238447A JP5967900B2 (en) | 2011-10-31 | 2011-10-31 | Taste improving agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011238447A JP5967900B2 (en) | 2011-10-31 | 2011-10-31 | Taste improving agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013094089A JP2013094089A (en) | 2013-05-20 |
JP5967900B2 true JP5967900B2 (en) | 2016-08-10 |
Family
ID=48616745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011238447A Active JP5967900B2 (en) | 2011-10-31 | 2011-10-31 | Taste improving agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5967900B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107072218B (en) * | 2014-12-22 | 2020-12-08 | Mc食品科技株式会社 | Antibacterial agent and method for inhibiting bacterial growth in food or beverage |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005052041A (en) * | 2003-08-01 | 2005-03-03 | Hosoda Shc:Kk | Seasoning composition |
EP1790239B1 (en) * | 2004-09-14 | 2013-01-30 | Hosoda SHC Inc. | Gnetum extract |
WO2006137139A1 (en) * | 2005-06-23 | 2006-12-28 | Gifu Research And Development Foundation | Method of isolating mangosteen and drug and health food containing the same |
US20100330137A1 (en) * | 2008-03-10 | 2010-12-30 | Mauro Mantovani | High bioavailability formulation of mangosteen and manufacturing process thereof |
-
2011
- 2011-10-31 JP JP2011238447A patent/JP5967900B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013094089A (en) | 2013-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPWO2006014028A1 (en) | Sweet potato stem and leaf extract and use thereof | |
CN1907060A (en) | Instant pu'er tea and its preparation method | |
JP5730989B2 (en) | Method for producing omega fatty acid-containing extract from plants using supercritical carbon dioxide extraction | |
JP5685752B2 (en) | Blood flow promoting agent | |
JP5285194B1 (en) | Food and drink | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
JP6234837B2 (en) | Beverage | |
JP2014047213A (en) | Composition for releasing stress or for improving sleep disorder which contains fermented substance of mixture of oyster and seaweeds as active ingredient, and method of manufacturing the same | |
JP5594819B2 (en) | Composition for improving lipid metabolism | |
JP2008056572A (en) | Water-soluble composition containing gingerol, method for producing water-soluble composition containing gingerol, and food, drink, cosmetic and medicine containing water-soluble composition containing gingerol | |
JP2007222116A (en) | Health food and drink | |
JP2008214191A (en) | Agent for suppressing accumulation of lipid in liver | |
KR101710518B1 (en) | Method for preparing functional pills with nyoa fruticans and jaggery, and functional pills by the method | |
JP5654290B2 (en) | Angiotensin converting enzyme inhibitory peptide and method for producing the same. | |
JP5967900B2 (en) | Taste improving agent | |
JP2007230881A (en) | Anti-fatigue composition | |
JP2006304766A (en) | Health food | |
JP2008208030A (en) | Inhibitor for lipid accumulation in liver | |
JP2007045751A (en) | Liver function-activating agent | |
JP4580447B2 (en) | Agaricus-containing composition | |
KR20120118174A (en) | Composition comprising seacucumber extract having anti-oxidation | |
JP2008125454A (en) | Dietary supplement and method for producing the same | |
KR101338532B1 (en) | Composition for preventing or treating colon cancer containing extract of sea cucumber | |
JP2005053786A (en) | Food and drink comprising extract derived from citrus pericarp and having inhibitory action on blood pressure rise | |
JP7408466B2 (en) | Oral composition and method for improving harsh taste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140901 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150624 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150721 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150914 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160118 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160226 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160705 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160705 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5967900 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |